Samir Ounzain Founder of HAYA Therapeutics Backed byAlexandria Venture InvestmentsSofinnova PartnersJean DeleageJoel MarcusLucia FaccioPeter M. Moglia LinkedIn SourcesHAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases — 2025-05 Browse all founders · Browse investors
